European Archives - Page 1106 of 1260 - European Medical Journal

EMJ

Yoga and Acupuncture: Alternative Approaches for Chronic Pain Management

COMPLEMENTARY health approaches have been employed in conjunction with standard drug-based therapeutic options to assist in chronic pain management…

EMJ

Targeting Senescent Cells Could Prevent Osteoarthritis

EVIDENCE has been found that cellular senescence, whereby cells stop dividing, causes osteoarthritis (OA), and that targeting these cells may treat or…

EMJ Urology 4 [Suppl 15] 2016

Benign prostatic hyperplasia (BPH) is common in men aged >60 years, affecting urinary and bladder function. Due to the progressive nature of the disease…

GreenLight XPS™ Vaporisation of the Prostate Has Proven Cost-Effective

Benign prostatic hyperplasia (BPH) is common in men aged >60 years, affecting urinary and bladder function. Due to the progressive nature of the disease…

EMJ

Genome Project Launch

Imagine. When you are well, the last thing you have on your mind is your health. We all take feeling normal for granted. When we feel right, all is fine.

GreenLight XPS™Laser Therapy System: A True Day Case Procedure

The National Institute for Clinical Health Care and Excellence (NICE) has given favourable guidance for GreenLight XPS™, advising that is Cost Saving…

ESMO 2016 Poster Abstracts Published Online Today

Lugano-Copenhagen, September 28, 2016 – Abstracts to be presented as Posters or Poster Discussions at ESMO 2016 Congress will be published online today…

EMJ

An interview with Dr Carl Lavie at the 2016 ESC Congress

An interview with Dr Carl Lavie (Medical Director, Cardiac Rehabilitation and Prevention) at the 2016 European Society of Cardiology Congress, Rome, Italy.

EMJ

An interview with Dr Javed Butler at the 2016 ESC Congress

An interview with Dr Javed Butler (Chief of the Cardiology Division, Stony Brook University) at the 2016 European Society of Cardiology Congress, Rome…

EMJ

An interview with Dr Bill Sasiela at the 2016 ESC Congress

An interview with Dr Bill Sasiela (Regeneron Pharmaceuticals, New York, USA) at the 2016 European Society of Cardiology Congress, Rome, Italy.